{
    "code": "06010978",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06010978",
    "time": "2016-11-18 23:30:17",
    "許可證字號": "衛署醫器輸字第010978號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/05\/29",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "103\/12\/27",
    "發證日期": "93\/12\/27",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00601097800",
    "中文品名": "&quot;日新&quot;倍利骨關節腔注射劑",
    "英文品名": "&quot;NISSIN&quot; LUMISTERON DISPO",
    "效能": "退化性膝關節炎用。",
    "醫器規格": "2.5公撮注射筒裝。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "N骨科用裝置",
    "醫器次類別一": "",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        "HYALURONATESODIUM(EQTOSODIUMHYALURONATE)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0611904200  合誠化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M260879000  NISSIN PHARMACEUTICAL  CO., LTD.",
        "製造廠廠址": "2-3-1,SHOGEHIGASHI, TENDO-CITY,YAMAGATA-PREF., 994-0069, JAPAN",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5236001210",
            "成分名稱": "HYALURONATE SODIUM ( EQ TO SODIUM HYALURONATE )",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "060109780001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06010978&Seq=001&Type=9"
        }
    ]
}